따라서 HBsAg, 항 HB, 항 HBC와 같은 혈청학적 검사는 환자가 HCV와 HBV에 감염되었는지 여부를 판단하기 위해 DAA 치료 전에 권장된다.
Therefore, serologic tests such as HBsAg, anti HBs, and anti HBc are recommended before DAA therapy to determine whether a patient has HCV and HBV coinfection.